Thinking of joining a study?

Register your interest

Become a volunteer?

NCT06484374 | NOT YET RECRUITING | Hematoma Brain

A Study of Minimally Invasive Surgical Strategies for Robot-assisted Supratentorial Large Hematoma
Sponsor:

The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School

Brief Summary:

The AI robot is used to design precise coordinates and access routes for hypertensive cerebral hemorrhage patients with large supratentorial hematomas in conjunction with imaging data, to clarify the therapeutic efficacy of robotic-assisted endoscopic debridement of precise minimally invasive surgical system for perioperative and long-term functional recovery of supratentorial hematomas, and to ultimately achieve the improvement of prognosis for this group of patients, and to alleviate the economic burdens on the society and the families

Condition or disease

Hematoma Brain

Intervention/treatment

Robot-assisted minimally invasive treatment

Phase

NA

Detailed Description:

In this randomized controlled study, we investigated the efficacy of robotic assistance for supratentorial large hematomas by comparing robotic-assisted minimally invasive removal of supratentorial large hematomas with conventional surgical hematoma removal. Our main comparisons were the 6-month mortality rate and good prognosis rate, and the main evaluation indexes included mRS score and GOS score.

Study Type : INTERVENTIONAL
Estimated Enrollment : 240 participants
Masking : TRIPLE
Primary Purpose : TREATMENT
Official Title : A Study of Minimally Invasive Surgical Strategies for Robot-assisted Supratentorial Large Hematoma
Actual Study Start Date : 2025-01-01
Estimated Primary Completion Date : 2027-06-30
Estimated Study Completion Date : 2027-12-31

Information not available for Arms and Intervention/treatment

Ages Eligible for Study: 18 Years to 70 Years
Sexes Eligible for Study: ALL
Accepts Healthy Volunteers:
Criteria
Inclusion Criteria
  • 1. Patients who were diagnosed by imaging (CT, CTA, etc.), measured by the ABC/2 method, and clearly recognized as having a supratentorial hypertensive cerebral hemorrhage.
  • Patients with hematoma volume \>30mL and GCS score ≥5;
  • 2. The patient's age is 18-70 years old; Patients aged 18-70 years;
  • 3. Time from onset to surgery ≤72h;
  • 4. Repeat CT scan at least 6 hours after the diagnostic CT scan showed that the hematoma was stable;
  • 5. SBP \<180 mmHg was recorded near the time of random assignment;
  • 6. mRS score ≤1 in the past medical history;
  • 7. Patient/family informed and signed informed consent.
Exclusion Criteria
  • 1. The hematoma is not located on the curtain or the volume of the hematoma is less than 30 ml;
  • 2. The onset of the disease is more than 3 days at the time of admission; Secondary cerebral hemorrhage (secondary causes such as aneurysm, vascular malformation, hemorrhagic transformation of cerebral infarction, tumor, trauma, drug-related or abnormal coagulation mechanism).
  • 3. secondary causes such as aneurysm, vascular malformation, hemorrhagic transformation of cerebral infarction, tumor, trauma, drug-related or abnormal coagulation mechanism);
  • 4. Presence of serious immune diseases (e.g., cirrhosis, malignant tumors, rheumatic immune diseases, etc.);
  • 5. Poor compliance or inappropriate for enrollment as judged by the investigator.
A Study of Minimally Invasive Surgical Strategies for Robot-assisted Supratentorial Large Hematoma

Location Details

NCT06484374

Please Choose a site

How to Participate

Want to participate in this study, select a site at your convenience, send yourself email to get contact details and prescreening steps.

Locations

No Location Found